Related Experiment Video
Updated: May 29, 2025
07:46
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
Published on: April 30, 2021
4.6K
Micro Immune Response On-chip (MIRO) models the tumour-stroma interface for immunotherapy testing.
Alice Perucca1, Andrea Gómez Llonín2,3, Oriol Mañé Benach1
1Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute for Science and Technology (BIST), Barcelona, Spain.
Nature Communications
|February 3, 2025
Summary
A new in vitro model, MIRO, reveals how tumor microenvironment structures impact immunotherapy effectiveness. It shows stromal barriers cause immune exclusion, but IL2 therapy can overcome this to restore anti-cancer responses.
Area of Science:
- Oncology
- Immunology
- Biotechnology
Background:
- Immunotherapies show variable efficacy in cancer patients.
- Understanding tumor microenvironment (TME) interactions is crucial for improving treatment outcomes.
- In vitro models are needed to study TME complexity and immune cell interactions.
Purpose of the Study:
- To develop a novel in vitro platform, MIRO, for modeling the tumor/stroma interface and immune cell interactions.
- To investigate the role of stromal barriers in immune exclusion and resistance to antibody-dependent cellular cytotoxicity (ADCC).
- To evaluate the potential of interleukin-2 (IL2)-driven immunomodulation in overcoming TME-mediated immunosuppression.
Main Methods:
- Development of MIRO, a fully humanized in vitro platform.
- Spatial modeling of the tumor-stroma interface.
- Assessment of immune cell interactions with cancer cells and stromal components.
- Evaluation of targeted therapy efficacy and IL2-driven immunomodulation.
Main Results:
- Stromal barriers were found to mediate immune exclusion, protecting cancer cells from ADCC.
- IL2 administration enhanced immune cell velocity and spreading.
- IL2-driven immunomodulation restored anti-cancer responses in models with refractory tumors.
- MIRO platform demonstrated translational value in studying TME-driven therapy resistance.
Conclusions:
- The MIRO platform provides a valuable tool for dissecting TME influences on immune responses.
- Spatial organization of the TME significantly impacts immunotherapy sensitivity and resistance.
- Targeted immunomodulation strategies, like IL2 therapy, can overcome stromal barriers to enhance anti-cancer immunity.
